Results 101 to 110 of about 723 (152)

From awareness to action: building monitoring capacity for tobacco and nicotine industry interference-experience from the JA PreventNCD project. [PDF]

Eur J Public Health
Voutilainen T, Cnockaert S, Jensson V, Jeras Z, Koprivnikar H, Sammel A, Vandevijvere S, Ollila H.   +7 more
europepmc   +1 more source

Understanding Malicious Accounts in Online Political Discussions: A Multilayer Network Approach. [PDF]

Sensors (Basel), 2021
Nguyen NL, Wang MH, Dai YC, Dow CR.
europepmc   +1 more source

Lobbying, fast and slow: principles of influence beyond reason. [PDF]

Interest Groups Advocacy
De Bruycker I.
europepmc   +1 more source

Opposition to Youth e-Cigarette Prevention Campaigns on Twitter and TikTok: Cross-Platform Observational Mixed Methods Analysis. [PDF]

J Med Internet Res
Carter CC, Page S, Borowiecki M, Kostygina G, Emery SL, Feng M.   +5 more
europepmc   +1 more source

The development of public engagement as a core institutional role for parliaments. [PDF]

J Legis Stud, 2023
Leston-Bandeira C, Siefken ST.
europepmc   +1 more source

Resisting industry narratives: guidance to avoid tobacco and nicotine industry framing. [PDF]

Health Promot Int
Maddox R, Diaz A, Waa A, Teddy L, Telford R, Pope S, Heris C.   +6 more
europepmc   +1 more source

Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review. [PDF]

Int J Technol Assess Health Care, 2023
Holtorf AP, Danyliv A, Krause A, Hanna A, Venable Y, Mattingly TJ, Huang LY, Pierre M, Silveira Silva A, Walsh D.   +9 more
europepmc   +1 more source

Social bots spoil activist sentiment without eroding engagement. [PDF]

Sci Rep
Li L, Vásárhelyi O, Vedres B.
europepmc   +1 more source

Bad Medicine: Nofreelunch. [PDF]

Br J Gen Pract, 2019
Spence D.
europepmc   +1 more source

Fake reviews on online platforms: perspectives from the US, UK and EU legislations. [PDF]

SN Soc Sci, 2021
Martínez Otero JM.
europepmc   +1 more source